31Z

2-(3-chlorophenoxy)-3-fluoro-4-{[(3S)-3-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)piperidin-1-yl]methyl}benzoic acid

Created:	2014-05-23
Last modified:	2014-06-11

Find Related PDB Entry
1 entries where 31Z is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	57
Chiral Atom Count	1
Bond Count	60
Aromatic Bond Count	12

2D diagram of 31Z

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	2-(3-chlorophenoxy)-3-fluoro-4-{[(3S)-3-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)piperidin-1-yl]methyl}benzoic acid
Systematic Name (OpenEye OEToolkits)	2-(3-chloranylphenoxy)-3-fluoranyl-4-[[(3S)-3-[5-methyl-2,4-bis(oxidanylidene)pyrimidin-1-yl]piperidin-1-yl]methyl]benzoic acid
Formula	C₂₄ H₂₃ Cl F N₃ O₅
Molecular Weight	487.908
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(O)c2ccc(c(F)c2Oc1cccc(Cl)c1)CN4CCCC(N3C=C(C(=O)NC3=O)C)C4
SMILES	CACTVS	3.385	CC1=CN([CH]2CCCN(C2)Cc3ccc(C(O)=O)c(Oc4cccc(Cl)c4)c3F)C(=O)NC1=O
SMILES	OpenEye OEToolkits	1.7.6	CC1=CN(C(=O)NC1=O)C2CCCN(C2)Cc3ccc(c(c3F)Oc4cccc(c4)Cl)C(=O)O
Canonical SMILES	CACTVS	3.385	CC1=CN([C@H]2CCCN(C2)Cc3ccc(C(O)=O)c(Oc4cccc(Cl)c4)c3F)C(=O)NC1=O
Canonical SMILES	OpenEye OEToolkits	1.7.6	CC1=CN(C(=O)NC1=O)[C@H]2CCCN(C2)Cc3ccc(c(c3F)Oc4cccc(c4)Cl)C(=O)O
InChI	InChI	1.03	InChI=1S/C24H23ClFN3O5/c1-14-11-29(24(33)27-22(14)30)17-5-3-9-28(13-17)12-15-7-8-19(23(31)32)21(20(15)26)34-18-6-2-4-16(25)10-18/h2,4,6-8,10-11,17H,3,5,9,12-13H2,1H3,(H,31,32)(H,27,30,33)/t17-/m0/s1
InChIKey	InChI	1.03	CFELMOUQZGRYTG-KRWDZBQOSA-N

Related Resource References

Resource Name	Reference
PubChem	74331718
ChEMBL	CHEMBL3297962

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.